skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: The Montley Fool is highly recommending Acuity Ads
as a strong buy with great potential and consider it a must have in your portfolio. What are your thoughts on this stock rebounding. Would you recommend buying at this price and do you share the same optimism??? Thanks for taking my question.

Read Answer Asked by Homer on March 30, 2022
Q: Hi Peter and 5i Team
Have held ENGH for several years in a LIF. I like the dividend of SYZ for income and am considering switching mainly for the dividend. I believe you rate ENGH higher than SYZ but like them both. Which do you think will make a better recovery? Is this a reasonable move?
Thanks
Gary
Read Answer Asked by Gary on March 29, 2022
Q: I know the drop in gross profits this quarter was an unwelcome surprise - down 20% after earnings release. Management calls it atypical issuesThe question is, do you think this is a bump in the road or is it a chronic issue in the business plan. They seem to have huge back log, they map out very bright future revenues... what are red flags here? Is this a buying opportunity?
Read Answer Asked by Harry on March 28, 2022
Q: I tend to hold either 3% or 5% positions in companies I own. If you were to own the above companies, which ones would you be inclined to own at a 3% level and which ones at a 5% level? If you would not be inclined to hold one or more of these companies at all, please indicate.
Thanks for a great service and have a well deserved weekend break. ram
Read Answer Asked by Ray on March 28, 2022
Q: SIS dropped 0.63 the day after Q results.Then the following day (3/25) it was up $1.05 to $17.92.The G & M reported as follows.NA sees significant long term upside with exceptional backlog,a$23.50 target price & a outperform rating. Desjardins says it is too cheap to ignore with a $25.50 TP & Buy. Any other news to prompt the big increase,& u comments.Txs for u usual great services & views.
Read Answer Asked by Peter on March 28, 2022
Q: Savaria has been heading downwards for the last six months, correcting by roughly 25% from its peak in September 2021. It represents 2% of my portfolio as I am writing. I have read the initial commentary on SIS posted to the message board, and I understand that your group may still be digesting the content of the recent investor's call from earlier today.

I would like to hear your thoughts on whether it is more prudent to wait for management to right the ship, so to speak, or if better opportunities lie elsewhere. If I were to sell Savaria, which opportunities within the healthcare space would you deem worthy of investment? Thanks so much, and I look forward to your response.
Read Answer Asked by Domenic on March 25, 2022